Böger RH - Search Results

1

FXR agonist INT-747 upregulates DDAH expression and enhances insulin sensitivity in high-salt fed Dahl rats.

Ghebremariam YT, Yamada K, Lee JC, Johnson CL, Atzler D, Anderssohn M, Agrawal R, Higgins JP, Patterson AJ, Böger RH, Cooke JP. Ghebremariam YT, et al. Among authors: boger rh. PLoS One. 2013 Apr 4;8(4):e60653. doi: 10.1371/journal.pone.0060653. Print 2013. PLoS One. 2013. PMID: 23593273 Free PMC article.

2

Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia.

Böger RH, Bode-Böger SM, Szuba A, Tsao PS, Chan JR, Tangphao O, Blaschke TF, Cooke JP. Böger RH, et al. Circulation. 1998 Nov 3;98(18):1842-7. doi: 10.1161/01.cir.98.18.1842. Circulation. 1998. PMID: 9799202 Clinical Trial.

3

Asymmetric dimethylarginine increases mononuclear cell adhesiveness in hypercholesterolemic humans.

Chan JR, Böger RH, Bode-Böger SM, Tangphao O, Tsao PS, Blaschke TF, Cooke JP. Chan JR, et al. Among authors: boger rh. Arterioscler Thromb Vasc Biol. 2000 Apr;20(4):1040-6. doi: 10.1161/01.atv.20.4.1040. Arterioscler Thromb Vasc Biol. 2000. PMID: 10764670

4

An endogenous inhibitor of nitric oxide synthase regulates endothelial adhesiveness for monocytes.

Böger RH, Bode-Böger SM, Tsao PS, Lin PS, Chan JR, Cooke JP. Böger RH, et al. J Am Coll Cardiol. 2000 Dec;36(7):2287-95. doi: 10.1016/s0735-1097(00)01013-5. J Am Coll Cardiol. 2000. PMID: 11127475 Free article.

5

Asymmetric dimethylarginine (ADMA): a key regulator of nitric oxide synthase.

Böger RH, Vallance P, Cooke JP. Böger RH, et al. Atheroscler Suppl. 2003 Dec;4(4):1-3. doi: 10.1016/s1567-5688(03)00027-8. Atheroscler Suppl. 2003. PMID: 14664896 No abstract available.

6

Determination of asymmetric dimethylarginine (ADMA) using a novel ELISA assay.

Schulze F, Wesemann R, Schwedhelm E, Sydow K, Albsmeier J, Cooke JP, Böger RH. Schulze F, et al. Among authors: boger rh. Clin Chem Lab Med. 2004;42(12):1377-83. doi: 10.1515/CCLM.2004.257. Clin Chem Lab Med. 2004. PMID: 15576299

7

ADMA: an emerging cardiovascular risk factor.

Böger RH, Cooke JP, Vallance P. Böger RH, et al. Vasc Med. 2005 Jul;10 Suppl 1:S1-2. doi: 10.1177/1358836X0501000101. Vasc Med. 2005. PMID: 16444862 No abstract available.

8

Extensive characterization of the human DDAH1 transgenic mice.

Schwedhelm E, von Leitner EC, Atzler D, Schmitz C, Jacobi J, Meinertz T, Münzel T, Baldus S, Cooke JP, Böger RH, Maas R, Sydow K. Schwedhelm E, et al. Among authors: boger rh. Pharmacol Res. 2009 Dec;60(6):494-502. doi: 10.1016/j.phrs.2009.08.001. Epub 2009 Aug 8. Pharmacol Res. 2009. PMID: 19666120

9

Symmetric dimethylarginine predicts all-cause mortality following ischemic stroke.

Schulze F, Carter AM, Schwedhelm E, Ajjan R, Maas R, von Holten RA, Atzler D, Grant PJ, Böger RH. Schulze F, et al. Among authors: boger rh. Atherosclerosis. 2010 Feb;208(2):518-23. doi: 10.1016/j.atherosclerosis.2009.06.039. Epub 2009 Jul 23. Atherosclerosis. 2010. PMID: 19700158

10

Dimethylarginine dimethylaminohydrolase-1 transgenic mice are not protected from ischemic stroke.

Leypoldt F, Choe CU, Gelderblom M, von Leitner EC, Atzler D, Schwedhelm E, Gerloff C, Sydow K, Böger RH, Magnus T. Leypoldt F, et al. Among authors: boger rh. PLoS One. 2009 Oct 7;4(10):e7337. doi: 10.1371/journal.pone.0007337. PLoS One. 2009. PMID: 19809508 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

313 results

Search Page